Daily Cardiology
Episodes
ESC 2025: β-blockers after myocardial infarction with mildly reduced ejection fraction
05 Jan 2026
Contributed by Lukas
📚 ESC 2025 Coverage: Expanding the Benefit Zone: Can β Blockers Help Post-MI Patients with Mildly Reduced Ejection Fraction? by Dr. Yahyavi, Cardi...
ESC 2025: SMuRF-less but inflamed
04 Jan 2026
Contributed by Lukas
📚 ESC 2025 Coverage: The SMuRF-less Illusion: Inflammation Unmasks Hidden Cardiovascular Risk in Healthy Women, by Dr. Hafezi, Cardiovascular Speci...
ESC 2025: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
03 Jan 2026
Contributed by Lukas
📚 ESC 2025 Coverage: A Classic Revived: Digitoxin Lowers Risk in HFrEF When Added to Modern Therapy, by Dr. Talasaz, Clinical Pharmacist.
ESC 2025: Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
03 Jan 2026
Contributed by Lukas
Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy
ESC 2025: Immediate versus staged complete revascularisation during index admission in patients
02 Jan 2026
Contributed by Lukas
📚 ESC 2025 Coverage: All at Once or One Step at a Time? Immediate Revascularisation Falls Short of Non-Inferiority in STEMI Patients, by Dr. Soltan...
ESC 2025: Remote Screening for Asymptomatic Atrial Fibrillation
01 Jan 2026
Contributed by Lukas
📚 ESC 2025 Coverage: Finding the Silent Beat: Remote ECG Screening Slightly Boosts Atrial Fibrillation Detection, by Dr. Tahmtan, Fellowship of Ele...
ESC 2025: Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery
31 Dec 2025
Contributed by Lukas
📚 ESC 2025 Coverage: Cholesterol Crushed, But Grafts Still Failed: Evolocumab Misses the Mark in NEWTON-CABG, by Dr. Ghavidel, Cardiovascular Surge...
ESC 2025: Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery
30 Dec 2025
Contributed by Lukas
📚 ESC 2025 Coverage: Cholesterol Crushed, But Grafts Still Failed: Evolocumab Misses the Mark in NEWTON-CABG, by Dr. Ghavidel, Cardiovascular Surge...
ESC 2025: Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome
30 Dec 2025
Contributed by Lukas
📚 ESC 2025 Coverage: More Isn’t Always Better: Dual Antiplatelet Therapy Falls Short After CABG for ACS, by Dr. Mehrpouya, Interventional Cardiol...
ESC 2025: Vericiguat for patients with heart failure and reduced ejection fraction across the risk s
29 Dec 2025
Contributed by Lukas
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrumVICTORIA and VICTOR Clinical Trials📚 ESC 2025 Cove...
ESC 2025: Reduction of Antihypertensive Treatment in Nursing Home Residents
28 Dec 2025
Contributed by Lukas
Reduction of Antihypertensive Treatment in Nursing Home Residents📚 ESC 2025 Coverage: Taking the Pressure Off, Gently: Can Fewer BP Pills Help Frai...
ESC 2025: High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults
27 Dec 2025
Contributed by Lukas
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults📚 ESC 2025 Coverage: Double the Dose, Double the Defense? by Dr. S...
ESC 2025: B. Aminian, MD
27 Dec 2025
Contributed by Lukas
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST)
Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)
27 Dec 2025
Contributed by Lukas
Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)
Impact 52: FINEARTS-HF: Modes of Death in HFmrEF & HFpEF
26 Dec 2025
Contributed by Lukas
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF RCT📚 Impact 52: Finerenone and mod...
Impact 51: Thrombolysis after recent DOAC intake
26 Dec 2025
Contributed by Lukas
📚 Impact 51: Intravenous thrombolysis in patients with ischemic stroke and recent ingestion of direct oral anticoagulants (DOACs), A review by Dr. ...
H&H Academy in 7 minutes, Episode 7
26 Dec 2025
Contributed by Lukas
💊 Hypertension and Hyperlipidemia at your fingertips!5️⃣ H&H Academy in 7 minutes, episode 7.
Impact 50: Thrombolysis before thrombectomy: A bridge not fallen
26 Dec 2025
Contributed by Lukas
📚 Impact 50: Thrombolysis before thrombectomy: A bridge not fallen, A review by Dr. Benam, Cardiovascular Specialist.
Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients
25 Dec 2025
Contributed by Lukas
🫀Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients, by Dr. Bikdeli, Cardiovascular specialist.
Impact 49: SGLT2 inhibitors in CKD: are they really effective in all patients?
24 Dec 2025
Contributed by Lukas
SGLT2 inhibitors in CKD: are they really effective in all patients?
Impact 48: DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR
23 Dec 2025
Contributed by Lukas
DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR
22nd ACC 2025 Congress Coverage: FLAVOUR II Trial
22 Dec 2025
Contributed by Lukas
22nd ACC 2025 Congress Coverage: FLAVOUR II Trial
Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis
22 Dec 2025
Contributed by Lukas
Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis
23rd ACC 2025 Congress Coverage: FAME 3 Trial
22 Dec 2025
Contributed by Lukas
23rd ACC 2025 Congress Coverage: FAME 3 Trial
21st ACC 2025 Congress Coverage: DapaTavi Trial
21 Dec 2025
Contributed by Lukas
🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors Progressing to New Standard After TAVI, DapaTAVI Trial, by Dr. Tahamtan, Fellowship of Electrophys...
19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease
21 Dec 2025
Contributed by Lukas
19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease
20th ACC 2025 Congress Coverage: ALLEPRE Trial
21 Dec 2025
Contributed by Lukas
🫀20th ACC.25 Congress Coverage: Alliance for secondary prevention after an acute coronary syndrome, ALLEPRE Trial, by Dr. Nasrollahizadeh, General ...
18th ACC 2025 Congress Coverage: SOUL Trial
21 Dec 2025
Contributed by Lukas
18th ACC 2025 Congress Coverage: SOUL Trial
L H&H Accademy in 7 Minutes, Ep 6, 50y M
19 Dec 2025
Contributed by Lukas
💊 Hypertension and Hyperlipidemia at your fingertips!5️⃣ H&H Academy in 7 minutes, episode 6
5th ACC 2025 Congress Coverage: PURSUIT Trial
09 Jun 2025
Contributed by Lukas
5th ACC 2025: PURSUIT Trial
13th ACC 2025 Congress Coverage: EquiOx Study
09 Jun 2025
Contributed by Lukas
13th ACC 2025: EquiOx Study
11th ACC 2025 Congress Coverage: HOST-BR Trial
09 Jun 2025
Contributed by Lukas
11th ACC 2025: HOST-BR Trial
12th ACC 2025 Congress Coverage: RIVAWAR Trial
09 Jun 2025
Contributed by Lukas
12th ACC 2025: RIVAWAR Trial
6th ACC 2025 Congress Coverage: FRESH-UP Study
09 Jun 2025
Contributed by Lukas
6th ACC 2025: FRESH-UP Study
14th ACC 2025 Congress Coverage: SBP < 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y
09 Jun 2025
Contributed by Lukas
14th ACC 2025: SBP < 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y
15th ACC 2025 Congress Coverage: DapaTAVI Trial
09 Jun 2025
Contributed by Lukas
15th ACC 2025: DapaTAVI Trial
9th ACC 2025 Congress Coverage: ALIGN-AR Trial
09 Jun 2025
Contributed by Lukas
9th ACC 2025: ALIGN-AR Trial
10th ACC 2025 Congress Coverage: FAIR-HF2 Trial
09 Jun 2025
Contributed by Lukas
10th ACC 2025: FAIR-HF2 Trial
16th ACC 2025 Congress Coverage: MI and Cardiovascular Risks Associated with Cannabis Use
09 Jun 2025
Contributed by Lukas
16th ACC 2025: MI and Cardiovascular Risks Associated with Cannabis Use
8th ACC 2025 Congress Coverage: BHF PROTECT-TAVI Trial
09 Jun 2025
Contributed by Lukas
8th ACC 2025: BHF PROTECT-TAVI Trial
17th ACC 2025 Congress Coverage: ALPACA Trial
09 Jun 2025
Contributed by Lukas
17th ACC 2025: ALPACA Trial
7th ACC 2025 Congress Coverage: WARRIOR Trial
09 Jun 2025
Contributed by Lukas
7th ACC 2025: WARRIOR Trial
4th ACC 2025 Congress Coverage: SUMMIT Trial
13 May 2025
Contributed by Lukas
4th ACC 2025: SUMMIT Trial
3rd ACC 2025 Congress Coverage: STRIDE Trial
13 May 2025
Contributed by Lukas
3rd ACC 2025: STRIDE Trial
2nd ACC 2025 Congress Coverage: ADVANCE-HTN Trial
13 May 2025
Contributed by Lukas
2nd ACC 2025: ADVANCE-HTN Trial
1st ACC 2025 Congress Coverage: SMART-CHOICE 3 Trial
13 May 2025
Contributed by Lukas
1st ACC 2025: SMART-CHOICE 3 Trial
5th Umbrella: Antithrombotic Therapy in Chronic Coronary Syndrome
26 Mar 2025
Contributed by Lukas
Antithrombotic Therapy in CCS
5th Umbrella: Antithrombotic Therapy in Acute Coronary Syndrome
26 Mar 2025
Contributed by Lukas
Antithrombotic Therapy in ACS
5th Umbrella: Antithrombotic Therapy in Venous Thromboembolism
26 Mar 2025
Contributed by Lukas
Antithrombotic Therapy in VTE
5th Umbrella: Antithrombotic Therapy in Atrial Fibrillation
26 Mar 2025
Contributed by Lukas
Antithrombotic Therapy in AF
Cardiac Point of Care Ultrasound (POCUS), Basic Echocardiography
21 Mar 2025
Contributed by Lukas
POCUS Basic Echocardiography
18th AHA 2024 Congress Coverage: CLEAR Trial
21 Feb 2025
Contributed by Lukas
18th AHA 2024: CLEAR Trial
17th AHA 2024 Congress Coverage: VANISH2 Trial
21 Feb 2025
Contributed by Lukas
17th AHA 2024: VANISH2 Trial
19th AHA 2024 Congress Coverage: OPTION Trial
21 Feb 2025
Contributed by Lukas
19th AHA 2024: OPTION Trial
14th AHA 2024 Congress Coverage: PHARM-HF A&F Trial
21 Feb 2025
Contributed by Lukas
14th AHA 2024: PHARM-HF A&F Trial
15th AHA 2024 Congress Coverage: TOPSPIN Trial
21 Feb 2025
Contributed by Lukas
15th AHA 2024: TOPSPIN Trial
Case Based Approach to Preventive Cardiology - Part 2
21 Feb 2025
Contributed by Lukas
Preventive Cardiology
Case Based Approach to Preventive Cardiology - Part 1
21 Feb 2025
Contributed by Lukas
Preventive Cardiology
16th AHA 2024 Congress Coverage: ALPACAR-360 Trial
21 Feb 2025
Contributed by Lukas
16th AHA 2024: ALPACAR-360 Trial
12th AHA 2024 Congress Coverage: SARAH Trial
08 Feb 2025
Contributed by Lukas
12th AHA 2024: SARAH Trial
13th AHA 2024 Congress Coverage: ENDEAVOR Trial
08 Feb 2025
Contributed by Lukas
13th AHA 2024: ENDEAVOR Trial
10th AHA 2024 Congress Coverage: BROOKLYN Trial
01 Feb 2025
Contributed by Lukas
10th AHA 2024: BROOKLYN Trial
11th AHA 2024 Congress Coverage: SUMMIT Trial
01 Feb 2025
Contributed by Lukas
11th AHA 2024: SUMMIT Trial
8th AHA 2024 Congress Coverage: KRAKEN Trial
21 Jan 2025
Contributed by Lukas
8th AHA 2024: KRAKEN Trial
6th AHA 2024 Congress Coverage: Nexiguran Ziclumeran for ATTR Cardiomyopathy
21 Jan 2025
Contributed by Lukas
6th AHA 2024: ATTR Cardiomyopathy
5th AHA 2024 Congress Coverage: REALIZE-K Trial
21 Jan 2025
Contributed by Lukas
5th AHA 2024: REALIZE-K Trial
Case Discussion 123: Evaluating Borderline QT Interval
21 Jan 2025
Contributed by Lukas
Case Discussion 123: Borderline QT Interval
4th AHA 2024 Congress Coverage: AI image-recognition for heart images, speed care
21 Jan 2025
Contributed by Lukas
4th AHA 2024: AI image-recognition for heart images
7th AHA 2024 Congress Coverage: TRIM‑AF
21 Jan 2025
Contributed by Lukas
7th AHA 2024: TRIM‑AF
Non-Adherence, The Elephant in the room
21 Jan 2025
Contributed by Lukas
Non-Adherence
9th AHA 2024 Congress Coverage: MYHY Trial
21 Jan 2025
Contributed by Lukas
9th AHA 2024: MYHY Trial
3rd AHA 2024 Congress Coverage: BRAIN-AF Trial
20 Jan 2025
Contributed by Lukas
3rd AHA 2024: BRAIN-AF Trial
Case Discussion 120: VTE prophylaxis in a CAD patient on ASA, after TKA
10 Jan 2025
Contributed by Lukas
Case Discussion 120: VTE prophylaxis
Case Discussion 119: CAC Score Guide in Aspirin and Statin Therapy
10 Jan 2025
Contributed by Lukas
Case Discussion 119: CAC Score
Hypertension and Hyperlipidemia Academy No. 21 - Part 2
10 Jan 2025
Contributed by Lukas
21st H&H Academy Session
Hypertension and Hyperlipidemia Academy No. 21 - Part 1
10 Jan 2025
Contributed by Lukas
21st H&H Academy Session
Case Discussion 118: Omalizumab in patient with cardivascular disease
10 Jan 2025
Contributed by Lukas
Case Discussion 118: Omalizumab in CVD
2nd AHA 2024 Congress Coverage: ENBALV Trial
10 Jan 2025
Contributed by Lukas
2nd AHA 2024: ENBALV Trial
1st AHA 2024 Congress Coverage: CLEAR SYNERGY (OASIS 9) Trial, Colchicine
30 Dec 2024
Contributed by Lukas
1st AHA 2024: OASIS 9 Trial
2nd Cardiology Online Grand Round: Invasive and Pharmacologic Approach to NSTE-ACS - Part 2
24 Dec 2024
Contributed by Lukas
Online Grand Round: Approach to NSTE-ACS
2nd Cardiology Online Grand Round: Invasive and Pharmacologic Approach to NSTE-ACS - Part 1
24 Dec 2024
Contributed by Lukas
Online Grand Round: Approach to NSTE-ACS
Introduction of Hypertension and Hyperlipidemia Academy for non-physician healthcare providers
23 Dec 2024
Contributed by Lukas
Intro of H&H Academy for non-physician healthcare providers
Hypertension and Hyperlipidemia Academy for non-physician healthcare providers - Part 1
15 Dec 2024
Contributed by Lukas
H&H Academy for non-physician healthcare providers
Hypertension and Hyperlipidemia Academy for non-physician healthcare providers - Part 2
15 Dec 2024
Contributed by Lukas
H&H Academy for non-physician healthcare providers
H&H Academy in 7 minutes, Episode 5
24 Nov 2024
Contributed by Lukas
H&H in 7 minutes, 5
Hypertension and Hyperlipidemia Academy No. 20 - Part 2
11 Nov 2024
Contributed by Lukas
20th H&H Academy Session
A Physical Activity and Sitting Time Balance Index and All-Cause Mortality Risk
11 Nov 2024
Contributed by Lukas
Sitting Time Balance Index
Peripheral Arterial Disease
11 Nov 2024
Contributed by Lukas
PAD
H&H Academy in 7 minutes, Episode 4
11 Nov 2024
Contributed by Lukas
H&H in 7 minutes, 4
ESPRIT Trial
11 Nov 2024
Contributed by Lukas
ESPRIT Trial
Hypertension and Hyperlipidemia Academy No. 20 - Part 1
11 Nov 2024
Contributed by Lukas
20th H&H Academy Session
Industry Payments to Cardiologists
11 Nov 2024
Contributed by Lukas
Industry Payments
37th ESC 2024 Congress Coverage: OCCUPI Trial
25 Oct 2024
Contributed by Lukas
37th ESC 2024: OCCUPI Trial
36th ESC 2024 Congress Coverage: SWEDEGRAFT Trial
25 Oct 2024
Contributed by Lukas
36th ESC 2024: SWEDEGRAFT Trial
35th ESC 2024 Congress Coverage: RIGHT Trial
25 Oct 2024
Contributed by Lukas
35th ESC 2024: RIGHT Trial
28th ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (1)
20 Oct 2024
Contributed by Lukas
28th ESC 2024: ESC 2024 CCS Guideline (1)
33rd ESC 2024 Congress Coverage: MATTERHORN Trial
20 Oct 2024
Contributed by Lukas
32nd ESC 2024: MATTERHORN Trial
32nd ESC 2024 Congress Coverage: Three Biomarkers and 30-Year Cardiovascular Outcomes in Women
20 Oct 2024
Contributed by Lukas
32nd ESC 2024: Cardiovascular Outcomes in Women
29th ESC 2024 Congress Coverage: Noise and Air Pollution as Risk Factors for Hypertension
20 Oct 2024
Contributed by Lukas
29th ESC 2024: Noise and Air Pollution as RF for HTN
31st ESC 2024 Congress Coverage: ESC 2024 Chronic Coronary Syndromes Guideline (3)
20 Oct 2024
Contributed by Lukas
31st ESC 2024: ESC 2024 CCS Guideline (3)